Gutierrez, IL
Alberto Gutierrez, Buffalo Grove, IL US
Patent application number | Description | Published |
---|---|---|
20080291936 | TEMPORARY BLOCK FLOW CONTROL IN WIRELESS COMMUNICATION DEVICE - A wireless communication device ( | 11-27-2008 |
Francisco Gutierrez, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20090106606 | METHOD AND APPARATUS FOR DETECTING AND ISOLATING CONTROLLER AREA NETWORK PERMANENT DOMINANT STATES - Detection of a permanent dominant state on a Controller Area Network node, occurring nearly simultaneously with development of the state, is used to the node from the network. Detection is independent of the application environment. | 04-23-2009 |
Greg M. Gutierrez, Hampshire, IL US
Patent application number | Description | Published |
---|---|---|
20090020618 | SYSTEM AND METHOD FOR ENVIRONMENTAL CONTROL OF AN ENCLOSURE - Unheated external air is drawn into an electronic component housing ( | 01-22-2009 |
20090023380 | APPARATUS AND METHOD FOR AIR CIRCULATION - An air circulation module ( | 01-22-2009 |
Joaquin Gutierrez, Waukegan, IL US
Patent application number | Description | Published |
---|---|---|
20110019952 | Self-Aligning Maintenance Free Bearing Unit for Agricultural Applications - A contamination-resistant bearing assembly includes an outer ring mounted within a housing and an inner ring rotatably supported from the outer ring. Inboard and outboard seal structures are disposed within a bearing space defined between the rings and prevent contaminants from entering a rolling element lubrication zone. A surface seal may also be included to protect the spherical interface between the housing and outer ring. The improved structure allows dynamic alignment of the bearing assembly when acted on by outside forces and also allows for extended operation under maintenance free conditions with no need for relubrication. | 01-27-2011 |
Jose Gutierrez, Mundelein, IL US
Patent application number | Description | Published |
---|---|---|
20090200198 | Dual compartment pouch - The invention provides a dual compartment pouch having first and second compartments that are separated from each other by an impervious inner sheet having a breathable membrane. The breathable membrane comprises a breathable material that is pervious to moisture and gases, and impervious to liquids as well as microorganisms. The breathable membrane allows a sterilizing gas to be introduced between the first and second compartments. The front and back sheets are sealed to the inner sheet to define the first and second compartments in which the inner sheet forms a common wall between the compartments. The breathable membrane is disposed towards a central portion of the inner sheet and is spaced apart from the seams joing the front and back sheets to the inner sheet. In one embodiment, a sterilized article is disposed in one compartment, and an absorbent packets are disposed in the other compartment. | 08-13-2009 |
20100051495 | Dual Compartment Pouch - The invention provides a dual compartment pouch having first and second compartments that are separated from each other by an impervious inner sheet having a breathable membrane. The breathable membrane comprises a breathable material that is pervious to moisture and gases, and impervious to liquids as well as microorganisms. The breathable membrane allows a sterilizing gas to be introduced between the first and second compartments. The front and back sheets are sealed to the inner sheet to define the first and second compartments in which the inner sheet forms a common wall between the compartments. The breathable membrane is disposed towards a central portion of the inner sheet and is spaced apart from the seams joining the front and back sheets to the inner sheet. In one embodiment, a sterilized article is disposed in one compartment, and an absorbent packets are disposed in the other compartment. | 03-04-2010 |
Robin Gutierrez, Gurnee, IL US
Patent application number | Description | Published |
---|---|---|
20140272932 | HCV NS3 RECOMBINANT ANTIGENS AND MUTANTS THEREOF FOR IMPROVED ANTIBODY DETECTION - The present disclosure relates to polypeptides, including fusions thereof, nucleic acids, vectors, host cells, immunodiagnostic reagents, kits, and immunoassays for use detecting the presence of HCV antibodies. More specifically, the present invention describes specific NS3 antigens that can be used for the detection of anti-HCV antibodies. | 09-18-2014 |
Robin A. Gutierrez, Gurnee, IL US
Patent application number | Description | Published |
---|---|---|
20090068635 | INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME - Indirectly labelled assay conjugates prepared by a method that includes the step of submitting the binding member comprised by the conjugate to denaturing conditions prior to labelling the binding member. The indirectly labelled assay conjugates demonstrate an increased sensitivity when employed in diagnostic assays compared to assay conjugates prepared by methods that do not include a step of submitting the binding member to denaturing conditions prior to labelling. Processes for the preparation of the indirectly labelled assay conjugates, methods of detecting an analyte comprising the use of the indirectly labelled assay conjugate and kits comprising the indirectly labelled conjugates are also provided. | 03-12-2009 |
20100279432 | INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME - Indirectly labelled assay conjugates prepared by a method that includes the step of submitting the binding member comprised by the conjugate to denaturing conditions prior to labelling the binding member. The indirectly labelled assay conjugates demonstrate an increased sensitivity when employed in diagnostic assays compared to assay conjugates prepared by methods that do not include a step of submitting the binding member to denaturing conditions prior to labelling. Processes for the preparation of the indirectly labelled assay conjugates, methods of detecting an analyte comprising the use of the indirectly labelled assay conjugate and kits comprising the indirectly labelled conjugates are also provided. | 11-04-2010 |
20110263436 | RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF OBTAINING AND USING SAME - Recombinant antibodies, including chimeric antibodies, specific for hepatitis C (HCV) antigenic proteins are provided. The recombinant antibodies specifically bind to diagnostically relevant regions of HCV proteins and are thus suitable for use, for example, as diagnostic reagents for the detection of HCV, and/or as standardization reagents or positive control reagents in assays for the detection of HCV. The recombinant antibodies can also be used in the treatment or prevention of a HCV infection. | 10-27-2011 |
20120202295 | MATERIALS AND METHODS FOR ASSAY OF ANTI-HEPATITIS C VIRUS (HCV) ANTIBODIES - A polypeptide comprising the contiguous amino acids 1-198 of SEQ ID NO: 2; a polypeptide, which comprises a contiguous amino acid sequence that is at least about 95% identical to the contiguous amino acids 1-198 of SEQ ID NO: 2, an epitope that is immunoreactive with an antibody that specifically binds to the core protein of hepatitis C virus (HCV), and an epitope that is immunoreactive with an antibody that specifically binds to the NS4 region of HCV; a nucleic acid encoding such a polypeptide; a host cell comprising such a nucleic acid; an immunodiagnostic reagent comprising such a polypeptide; a kit comprising such an immunodiagnostic reagent; and a method of determining the presence, amount, or concentration of anti-HCV antibodies in a test sample. | 08-09-2012 |
20120329176 | INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME - Indirectly labelled assay conjugates prepared by a method that includes the step of submitting the binding member comprised by the conjugate to denaturing conditions prior to labelling the binding member. The indirectly labelled assay conjugates demonstrate an increased sensitivity when employed in diagnostic assays compared to assay conjugates prepared by methods that do not include a step of submitting the binding member to denaturing conditions prior to labelling. Processes for the preparation of the indirectly labelled assay conjugates, methods of detecting an analyte comprising the use of the indirectly labelled assay conjugate and kits comprising the indirectly labelled conjugates are also provided. | 12-27-2012 |
Robin A. Gutierrez, Abbott Park, IL US
Patent application number | Description | Published |
---|---|---|
20140272933 | HCV ANTIGEN-ANTIBODY COMBINATION ASSAY AND METHODS AND COMPOSITIONS FOR USE THEREIN - The present invention generally relates to combination immunoassays, reagents and kits for simultaneous detection of HCV antigens and anti-HCV antibodies in a test sample. | 09-18-2014 |